Angiogenesis in pancreatic carcinoma: Thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival

Cancer

Volumn 92, Issue 7, 2001, Pages 1788-1797

  Fujioka, Shuichi ^a,b   Yoshida, Kazuhiko ^a   Yanagisawa, Satoru ^a   Kawakami, Makio ^a   Aoki, Teruaki ^a   Yamazaki, Yoji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Intratumoral microvessel density; Metastasis; p53; Pancreatic carcinoma; Prognostic factor; Thymidine phosphorylase; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; KI 67 ANTIGEN; PROTEIN P53; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK FACTOR; STROMA CELL;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035476246     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011001)92:7<1788::AID-CNCR1695>3.0.CO;2-Z     Document Type: Article

References (50)

1. Induction of angiogenesis during the transition from hyperplasia to neoplasia
2. What is the evidence that tumors are angiogenesis dependent?
3. The role of angiogenesis in tumor growth
4. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
5. Reciprocal paracrine interactions between tumour cells and endothelial cells: The 'angiogenesis progression' hypothesis
6. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
7. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
8. Relation of neovascularisation to metastasis of non-small-cell lung cancer
9. Prognostic and predictive value of tumor angiogenesis in ovarian carcinomas
10. Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous-cell carcinoma
11. Extent of tumour vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas
12. Tumour angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer
13. The role of vascular endothelial growth factor in pathological angiogenesis
14. The heparin-binding (fibroblast) growth factor family of proteins
15. In vitro angio-genesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases
16. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration
17. Basic fibroblast growth factor induces angiogenesis in vitro
18. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
19. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: Synergistic interaction with hypoxia
20. Angiogenic factor
21. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
22. Angiogenic activity of enzymes
23. Tumour suppressor genes and angiogenesis: The role of TP53 in fibroblasts
24. p53 and angiogenesis
25. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
26. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells
27. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
28. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study
29. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
30. Prognostic significance of KI-67 antigen and p53 protein expression in pancreatic ductal carcinoma: A study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material
31. Trend for the management of pancreatic adenocarcinoma in a hospitalized-based population (1980-1994)
32. Surgical resection of pancreatic cancer
33. Analysis of paraaortic lymph node involvement in pancreatic carcinoma: A significant indication for surgery?
34. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: Role of infiltrating cells
35. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages
36. Activated macrophages induce vascular proliferation
37. Macrophages and angiogenesis
38. Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis
39. How does extracellular matrix control capillary morphogenesis?
40. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases
41. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis
42. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression
43. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas
44. Prognostic significance of angiogenesis in human pancreatic cancer
45. Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma
46. Over expression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage
47. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
48. Clinical applications of research on angiogenesis
49. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1